Solvay Pharma
Solvay Pharma, a prominent division of Solvay Group, is headquartered in France and operates extensively across Europe, North America, and Asia. Established in 1995, the company has made significant strides in the pharmaceutical industry, focusing on innovative treatments in areas such as central nervous system disorders, women's health, and rare diseases. Renowned for its commitment to research and development, Solvay Pharma offers a range of unique products that address unmet medical needs, setting it apart in a competitive market. With a strong emphasis on sustainability and patient-centric solutions, the company has achieved notable recognition for its contributions to healthcare. As a key player in the pharmaceutical landscape, Solvay Pharma continues to advance its mission of improving patient outcomes through cutting-edge therapies.
DitchCarbon Score
How does Solvay Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Solvay Pharma's score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Solvay Pharma's reported carbon emissions
Solvay Pharma, headquartered in France, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. This lack of data suggests that Solvay Pharma may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction initiatives. However, without specific emissions data or targets, it is challenging to assess Solvay Pharma's position relative to its peers in terms of climate action. As the industry evolves, it is anticipated that Solvay Pharma will develop and disclose more comprehensive climate strategies and emissions data in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Solvay Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
